Vertaling van "uncertainties include among other things " (Nederlands → Frans) :

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments.
This release contains forward-looking information that involves substantial risks and uncertainties regarding Prevenar 13, including its potential benefits; and the success of the AMC project for vaccines. Such risks and uncertainties include, among other things, the uncertainties inherent in research and development; whether and when regulatory authorities in countries where regulatory applications for Prevenar 13 may be pending or may be submitted will approve such applications and their decisions regarding labeling and other matters that could affect its availability or commercial potential; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009, and in its reports on Form 10-Q and Form 8-K.

This release contains forward-looking information that involves substantial risks and uncertainties concerning the possibility of future dividend increases. Such risks and uncertainties include, among other things, the Company’s future financial performance as well as general economic, political, business, industry, regulatory and market conditions.
Such risks and uncertainties include, among other things, the Company’s future financial performance as well as general economic, political, business, industry, regulatory and market conditions.

This release contains forward-looking information about a potential joint venture between Pfizer and Zhejiang Hisun Pharmaceuticals (Hisun) including, among other things, the anticipated benefits there of, that involves substantial risks and uncertainties.
This information contained in this release is as of June 2, 2011, Pfizer assumes no obligation to update forward-looking statements contaiTned in this release as the result of new information or future events or developments. This release contains forward-looking information about a potential joint venture between Pfizer and Zhejiang Hisun Pharmaceuticals (Hisun) including, among other things, the anticipated benefits there of, that involves substantial risks and uncertainties.

These include, among other things, reasonable housing, healthcare, clothing, nutrition as well as child-education expenses.
Il s’agit, entre autres, du prix d’un logement décent, des coûts liés à la santé, à l’habillement et à la nourriture et du financement de l’éducation des enfants.

In order to be efficient, prevention requires among other things the spreading of information, viz. the broadcasting of quality information via the media, colloquia, conferences, and debates. In other words, this involves constantly repeating basic notions, talking about experiences of life and death in which everyone, if they are willing to, can recognise themselves or someone else.
Pour pouvoir agir, une prévention nécessite notamment de l’information: diffuser une information de qualité par les médias, colloques, conférences, débats; c’est-à-dire répéter inlassablement des notions simples, parler d’expériences de vie, de mort dans lesquelles chacun peut, s’il se le permet, se reconnaître ou y reconnaître quelqu’un.

Among other things, they are provided with the means to detect and diagnose depression in a quick and easy way.
On leur fournit entre autres des instruments qui leur permettent de détecter et de diagnostiquer la dépression de façon facile et rapide.

Nowadays, the manner in which suicidal patients are received and taken care of in Belgian emergency services as well as the prevention of recurrence depends, among other things, on the hospital to which those who have tried to put an end to their lives have been referred.
Actuellement en Belgique, la qualité de l’accueil et de la prise en charge de patients suicidaires aux services des urgences ainsi que la prévention des rechutes dépend entre autres de l’hôpital dans lequel la personne qui a tenté de mettre fin à ses jours a été orientée.

There is also ongoing patent litigation in several European countries including, among others, France, Germany, the Netherlands, the United Kingdom and Spain.
Des litiges relatifs aux brevets sont également en cours dans plusieurs pays européens, entre autres, en France, en Allemagne, aux Pays-Bas, au Royaume-Uni et en Espagne.